Related Experiment Video
Updated: Jul 8, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
HYENA detects oncogenes activated by distal enhancers in cancer
Anqi Yu1, Ali E Yesilkanal1, Ashish Thakur2
1Ben May Department for Cancer Research, University of Chicago, Chicago IL, USA.
Abstract:
Somatic structural variations (SVs) in cancer can shuffle DNA content in the genome, relocate regulatory elements, and alter genome organization. Enhancer hijacking occurs when SVs relocate distal enhancers to activate proto-oncogenes. However, most enhancer hijacking studies have only focused on protein-coding genes. Here, we develop a computational algorithm "HYENA" to identify candidate oncogenes (both protein-coding and non-coding) activated by enhancer hijacking based on tumor whole-genome and transcriptome sequencing data. HYENA detects genes whose elevated expression is associated with somatic SVs by using a rank-based regression model. We systematically analyze 1,146 tumors across 25 types of adult tumors and identify a total of 108 candidate oncogenes including many non-coding genes. A long non-coding RNA TOB1-AS1 is activated by various types of SVs in 10% of pancreatic cancers through altered 3-dimensional genome structure. We find that high expression of TOB1-AS1 can promote cell invasion and metastasis. Our study highlights the contribution of genetic alterations in non-coding regions to tumorigenesis and tumor progression.
Insights
Structural variations in cancer genomes can activate oncogenes. Our study identifies novel oncogenes, including non-coding genes, driven by enhancer hijacking, revealing new cancer mechanisms.
Area of Science:
- Genomics
- Cancer Biology
- Bioinformatics
Background:
- Somatic structural variations (SVs) can alter genome organization and gene expression in cancer.
- Enhancer hijacking, a mechanism where SVs relocate enhancers to activate proto-oncogenes, has primarily focused on protein-coding genes.
- Understanding SV-driven oncogene activation is crucial for cancer research.
Approach:
- Developed HYENA, a computational algorithm to identify candidate oncogenes (protein-coding and non-coding) activated by enhancer hijacking.
- Utilized tumor whole-genome and transcriptome sequencing data from 1,146 tumors across 25 adult cancer types.
- Employed a rank-based regression model to link elevated gene expression with somatic SVs.
Key Points:
- Identified 108 candidate oncogenes, including numerous non-coding genes, activated by enhancer hijacking.
- Discovered that the long non-coding RNA TOB1-AS1 is activated by SVs in 10% of pancreatic cancers via altered 3D genome structure.
- Demonstrated that high TOB1-AS1 expression promotes cell invasion and metastasis.
Conclusions:
- HYENA expands the scope of enhancer hijacking studies to include non-coding genes.
- Genetic alterations in non-coding regions significantly contribute to tumorigenesis and cancer progression.
- This work provides new insights into the role of SVs and non-coding elements in cancer development.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

